Security
SAVAW · FILANA THERAPEUTICS, INC.
SAVAWNASDAQWarrantHistorical · closed Dec 3, 2024CIK 1069530Updated Sep 24, 2026
Name history
CASSAVA SCIENCES INC · through Feb 19, 2026PAIN THERAPEUTICS INC · through Mar 25, 2019
Current security for this SEC filerFLNA · NASDAQ
SAVAW price & chart
Historical security
This listing closed Dec 3, 2024. Live provider charts are shown only for current listings.
Current security: FLNA
In the news
No coverage from other publishers is available.
Recent filings
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Items 3.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Submission of Matters to a Vote of Security Holders
Items 5.02, 5.07, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 118,355,000Source | 157,533,000Source | 151,663,000Source | 234,834,000Source |
| Property, Plant and Equipment, NetUSD | 20,646,000Source | 20,964,000Source | 21,854,000Source | 22,864,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | 37,000Source | 176,000Source | 622,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 95,502,000Source | 128,574,000Source | 121,136,000Source | 201,015,000Source |
| Assets, CurrentUSD | 97,709,000Source | 136,532,000Source | 129,633,000Source | 211,226,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,207,000Source | 7,958,000Source | 8,497,000Source | 10,211,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | — | 0Source | 122,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 43,952,000Source | 11,829,000Source | 14,195,000Source | 7,295,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | — |
| Common Stock, Value, IssuedUSD | 48,000Source | 48,000Source | 42,000Source | 42,000Source |
| Additional Paid in CapitalUSD | 570,439,000Source | 550,767,000Source | 518,195,000Source | 511,049,000Source |
| Retained Earnings (Accumulated Deficit)USD | -496,084,000Source | -405,111,000Source | -380,769,000Source | -283,552,000Source |
| Stockholders' Equity Attributable to ParentUSD | 74,403,000Source | 145,704,000Source | 137,468,000Source | 227,539,000Source |
| Liabilities and EquityUSD | 118,355,000Source | 157,533,000Source | 151,663,000Source | 234,834,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 43,834,000Source | 11,750,000Source | 14,195,000Source | 7,063,000Source |
| Operating Lease, Liability, CurrentUSD | — | — | 0Source | 104,000Source |
| Accounts Payable, CurrentUSD | — | — | — | 4,017,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | 0Source | 35,000Source |
| Other Liabilities, NoncurrentUSD | 118,000Source | 79,000Source | 0Source | 197,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | — | — | — | 2,280,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 19,582,000Source | 16,291,000Source | 4,586,000Source | 2,066,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | 33,993,000Source | -2,919,000Source | 6,896,000Source | -3,449,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -32,252,000Source | -116,929,000Source | -82,025,000Source | -77,514,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -581,000Source | -103,000Source | -414,000Source | -2,712,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 581,000Source | 103,000Source | 414,000Source | 2,712,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -239,000Source | 124,470,000Source | 2,560,000Source | 47,804,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | 201,015,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 19,582,000Source | 16,291,000Source | 4,586,000Source | 2,066,000Source |
| Amortization of Intangible AssetsUSD | 33,000Source | 180,000Source | 446,000Source | 497,000Source |
| DepreciationUSD | 903,000Source | 952,000Source | 1,084,000Source | 804,000Source |
| General and Administrative ExpenseUSD | 68,800,000Source | 71,809,000Source | 16,534,000Source | 11,988,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -90,973,000Source | -24,342,000Source | -97,217,000Source | -76,246,000Source |
| Operating ExpensesUSD | 95,390,000Source | 141,446,000Source | 105,957,000Source | 80,020,000Source |
| Operating Lease, ExpenseUSD | — | — | — | 100,000Source |
| Other Nonoperating Income (Expense)USD | -203,000Source | 411,000Source | 907,000Source | 997,000Source |
| Proceeds from Issuance of Common StockUSD | — | 0Source | 0Source | 47,329,000Source |
| Proceeds from Stock Options ExercisedUSD | 90,000Source | 918,000Source | 2,560,000Source | 475,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -95,390,000Source | -141,446,000Source | -105,957,000Source | -80,020,000Source |
| Other Nonoperating Income (Expense)USD | -203,000Source | 411,000Source | 907,000Source | 997,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -90,973,000Source | -24,342,000Source | -97,217,000Source | -76,246,000Source |
| Earnings Per Share, BasicUSD per share | -1.88Source | -0.53Source | -2.32Source | — |
| Earnings Per Share, DilutedUSD per share | -1.88Source | -1.46Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 48,297,000Source | 46,329,000Source | 41,932,000Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 48,297,000Source | 46,604,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 33,000Source | 180,000Source | 446,000Source | 497,000Source |
| General and Administrative ExpenseUSD | 68,800,000Source | 71,809,000Source | 16,534,000Source | 11,988,000Source |
| Interest and Other IncomeUSD | — | — | — | 2,777,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | 4,620,000Source | 8,510,000Source | 7,833,000Source | — |
| Operating ExpensesUSD | 95,390,000Source | 141,446,000Source | 105,957,000Source | 80,020,000Source |
| Operating Lease, ExpenseUSD | — | — | — | 100,000Source |
| Preferred Stock Dividends and Other AdjustmentsUSD | 0Source | 43,793,000Source | — | — |
| Research and Development ExpenseUSD | 26,590,000Source | 69,637,000Source | 89,423,000Source | — |